Akanda Corp.
(AKAN)
undefined
undefined%
At close: undefined
1.56
6.85%
After-hours Dec 13, 2024, 04:41 PM EST
Company Description
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally.
It intends to supply cannabis based medical and wellness products.
The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Akanda Corp.
| Country | GB |
| IPO Date | Mar 15, 2022 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 46 |
| CEO | Katharyn Field |
Contact Details
Address: 1a, 1b Learoyd Road New Romney, GB | |
| Website | https://www.akandacorp.com |
Stock Details
| Ticker Symbol | AKAN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001888014 |
| CUSIP Number | 00971M106 |
| ISIN Number | CA00971M2058 |
| Employer ID | 00-0000000 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Katharyn Field | Interim Chief Executive Officer & Executive Director |
| Dr. Gurcharn Deol B.A., M.A., Ph.D. | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 26, 2024 | 6-K | Filing |
| Nov 12, 2024 | 6-K | Filing |
| Oct 30, 2024 | 6-K | Filing |
| Oct 04, 2024 | 6-K | Filing |
| Oct 03, 2024 | 424B4 | Filing |
| Oct 02, 2024 | 6-K | Filing |
| Sep 20, 2024 | F-1/A | [Amend] Filing |
| Sep 16, 2024 | 6-K | Filing |
| Sep 05, 2024 | F-1 | Filing |
| Jul 25, 2024 | 6-K | Filing |